Skip to main content

Table 2 Liraglutide-induced changes in parameters relating to glucose metabolism.

From: Short-term effects of liraglutide on visceral fat adiposity, appetite, and food preference: a pilot study of obese Japanese patients with type 2 diabetes

 

Before treatment with liraglutide

After treatment with liraglutide

P value

sCPR(ng/mL)

1.87 ± 1.00

3.25 ± 1.19

< 0.0001

C-peptide Index

1.47 ± 0.75

2.76 ± 0.97

< 0.0001

HOMA-IR

3.52 ± 2.63

4.51 ± 3.27

0.468

Matsuda Index

3.09 ± 2.24

3.16 ± 1.99

0.820

Insulinogenic Index

0.18 ± 0.16

0.32 ± 0.30

0.058

Disposition Index

0.43 ± 0.27

0.76 ± 0.51

< 0.05

  1. Data are mean ± SD. sCPR; serum C-peptide immunoreactivity, HOMA-IR; homeostasis model assessment of insulin resistance.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840